NICE's initial draft guidance had raised concerns about the clinical evidence and economic model for vamorolone. However, new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback